A critical discovery in cancer research is arising with the use of nanobodies to reactivate mutated p53. This vital cancer inhibitor protein is frequently inactivated in many kinds of malignancies, resulting https://cruxbookmarks.com/story22037381/nanobodies-revive-tumor-suppressor-p53-a-potential-approach-for-malignant-management